Replies to post #680801 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Could you please use a paragraph break on occasion?

[Nemesis18]

Sir, In regards to ‘psuedoprogression’, shown in those who had the ‘vaccine’ , what were the OS rates ?

And presuming that this inflammatory response was probably short lived, why the need to change endpoints ?

This juncture in the trial, needs further close regulatory examination imho, as does ..

Did the Vaccine reduce the median OS in favourable genomic subgroups, and or those with more favourable histology ?

Where’s the IDH status for each patient ?
Mine was ‘Wildtype’…., and in the Who Reclassification, this info was critical to my re-diagnosis, nine years after the original.

[Nemesis18]

Any adjudicated decisions the Regulators ultimately make moving forward, must be respected by all.
And I absolutely include myself in that.

Before their summary findings, I will not be judged solely by the Court of Public Opinion.